Tesamorelin + Ipamorelin blend calculator
A two-peptide blend vial: tesamorelin and ipamorelin. Amounts per vial differ by seller. Work out how much of each peptide is in one draw, from the dose of one peptide or from the units you draw.
- Tesamorelin250 mcg50%
- Ipamorelin250 mcg50%
- Vial total
- 10 mg
- Total mg/mL
- 5
- Draws per vial
- 20
Tesamorelin + Ipamorelin: 10 units (0.1 mL) from a 10 mg vial + 2 mL water = 250 mcg Tesamorelin, 250 mcg Ipamorelin.
How the blend math works
Each peptide has its own concentration: its milligrams divided by the water you add. Whatever volume you draw, every peptide comes along in proportion. Dosing by one peptide sets the volume, and that volume sets the dose of all the others.
What is in a Tesamorelin + Ipamorelin vial
| Peptide | Amount per vial |
|---|---|
| Tesamorelin | Amounts differ by seller; check your vial label |
| Ipamorelin | Amounts differ by seller; check your vial label |
Tesamorelin is the only component with a label, and the label is narrow
Egrifta SV's label says it is not indicated for weight loss management because of its weight-neutral effect.[3]
The label says tesamorelin stimulates GH production and raises serum IGF-1, and that the effects of prolonged IGF-1 elevation are unknown.[3]
On interactions, the label says to monitor patients taking drugs metabolised by cytochrome P450, and that patients on glucocorticoid replacement for hypoadrenalism may require higher maintenance or stress doses.[3]
The label does not mention ipamorelin. Its cytochrome P450 interaction data come from a study with simvastatin.[3]
Ipamorelin has no label, and its human data are intravenous
Ipamorelin's phase 2 trial gave it by intravenous infusion to bowel-resection patients.[4]
FDA's safety-risk page notes that ipamorelin acetate contains unnatural amino acids, which add to the complexity of characterising the peptide.[5]
Together
A PubMed title/abstract search for ipamorelin with tesamorelin returned 6 records on 2 Oct 2026, and 0 are classed as a study of the pair.
Calculated from pubmed query (ipamorelin[tiab]) AND (tesamorelin[tiab] OR Egrifta[tiab] OR TH9507[tiab] OR "TH-9507"[tiab]); search date 2026-10-02; records returned 6; records classed as study of the pair 0. Formula: Counts copied from the combinations dataset (key ipamorelin__tesamorelin); no arithmetic applied.
An FDA warning letter from August names a 'Tesamorelin Ipamorelin Blend' sold online among products it considers unapproved new drugs.[6]
An example vial of 5 mg of each peptide is 50% tesamorelin by weight. Real product amounts are listed as pending.
Calculated from example mg 5, 5; composition basis pending (example only). Formula: 5 / (5 + 5) = 50%
Common questions
How many units of Tesamorelin + Ipamorelin for 250 mcg of Tesamorelin?
In an example 10 mg Tesamorelin + Ipamorelin vial (5 mg Tesamorelin, 5 mg Ipamorelin) mixed with 2 mL of water, Tesamorelin is at 2.5 mg/mL, so 250 mcg is 10 units (0.10 mL) on a U-100 syringe. That same draw also contains 250 mcg Ipamorelin.
How much of each peptide is in 10 units of Tesamorelin + Ipamorelin?
10 units on a U-100 syringe is 0.10 mL. From an example 10 mg Tesamorelin + Ipamorelin vial (5 mg Tesamorelin, 5 mg Ipamorelin) with 2 mL of water, that draw holds 250 mcg Tesamorelin, 250 mcg Ipamorelin.
Is tesamorelin plus ipamorelin studied together?
No: the dataset search returned 6 records mentioning both and none classed as a study of the pair.
Calculated from records returned 6; records classed as study of the pair 0. Formula: Counts copied from the combinations dataset (key ipamorelin__tesamorelin).
Is tesamorelin approved?
Yes, as Egrifta, but only for excess abdominal fat in HIV-infected adults with lipodystrophy.[3]
What does FDA say about the blend?
Its warning letter names the blend among unapproved new drugs.[6]
The peptides in Tesamorelin + Ipamorelin
Sources
- 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
- 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
- 3EGRIFTA SV prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
- 4Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.International journal of colorectal disease · 2014PMID 25331030Accessed 2 Oct 2026
- 5Official web pageOfficial web page · web page
- 6Official web pageOfficial web page · web page
Found an error? Report a correction.